KLN named full-line distributor for APT Medical’s coronary intervention products in Hong Kong

by

Jorhway Chong, Director – Integrated Logistics, Thailand & Regional Logistics Operations of KLN (third from right) and Fangyuan Liu, Deputy General Manager of APT Medical (fourth from right) sign the distribution agreement. KLN is officially named the full-line distributor for APT Medical’s coronary intervention products in Hong Kong.

KLN Logistics Group Limited (KLN) announced that its healthcare subsidiary, KLN Medical Limited (KLN Medical), is now the full-line distributor for APT Medical Inc.’s (APT Medical) coronary intervention products in Hong Kong. KLN Medical will promote and distribute APT Medical’s full coronary intervention portfolio while providing clinical application training, after-sales support and logistics services. This collaboration aims to strengthen support for medical professionals and patients and advance the adoption of percutaneous coronary intervention technologies in Hong Kong.

APT Medical offers a comprehensive portfolio of interventional cardiology products, encompassing key devices such as angiography triads, guiding catheters, percutaneous transluminal coronary angioplasty (PTCA) guidewires, microcatheters, extension catheters, and PTCA balloons. These products provide excellent patency and operational stability, meeting the demands of both routine and complex percutaneous coronary interventions. Leveraging KLN’s established medical logistics infrastructure, these products will be delivered efficiently to major public and private hospitals across Hong Kong. With extensive experience in medical device logistics, cold chain handling, warehousing and inventory management, KLN Medical provides responsive and flexible supply chain support to healthcare institutions, helping enhance clinical operational efficiency.

Samuel Lau, Managing Director – Integrated Logistics of KLN, said, “We are honoured to partner with APT Medical to offer more options to Hong Kong healthcare institutions and patients through cost-effective, reliable and advanced treatment solutions. With our flexible logistics solutions and commitment to service excellence, we will support the long-term development of the interventional cardiology device market in Hong Kong.”

Fangyuan Liu, Deputy General Manager of APT Medical, said, “As a leading manufacturer and supplier in the interventional cardiology device sector, we are delighted to establish a partnership with KLN Medical. Leveraging KLN’s extensive local experience and robust logistics capabilities in the Hong Kong market, we are confident in enabling more healthcare institutions and patients to benefit from our advanced, reliable and cost-effective coronary intervention solutions.”